Search results
Alembic Pharmaceuticals receives tentative US FDA approval for Ivosidenib Tablets, 250 mg - ET...
The Economic Times· 1 day agoIvosidenib is an isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with a...
Ivosidenib is an isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with a...